Health information technology and digital innovation for national learning health and care systems

A Sheikh, M Anderson, S Albala, B Casadei… - The Lancet Digital …, 2021 - thelancet.com
Health information technology can support the development of national learning health and
care systems, which can be defined as health and care systems that continuously use data …

SARS-CoV-2 infections in children and young people

S Felsenstein, CM Hedrich - Clinical immunology, 2020 - Elsevier
Though recent reports link SARS-CoV-2 infections with hyper-inflammatory states in
children, most children experience no/mild symptoms, and hospitalization and mortality rates …

[HTML][HTML] Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной …

ЕЛ Насонов, АМ Лила, ВИ Мазуров… - Научно …, 2021 - cyberleninka.ru
В середине 2021 года инфекция SARS-CoV-2 (Severe Acute Respiratory coronavirus 2),
вызвавшая пандемию коронавирусной болезни 2019 (coronavirus disease, COVID-19) …

Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic

E Peach, M Rutter, P Lanyon, MJ Grainge… - …, 2021 - academic.oup.com
Objectives To quantify the risk of death among people with rare autoimmune rheumatic
diseases (RAIRD) during the UK 2020 COVID-19 pandemic compared with the general …

Managing rheumatoid arthritis during COVID-19

R Roongta, A Ghosh - Clinical rheumatology, 2020 - Springer
The outbreak of coronavirus in the world has led to an uncertainty about treatment of
patients with autoimmune disorders because of their weakened immune system coupled …

[HTML][HTML] COVID-19 и дети

ЛС Намазова-Баранова, АА Баранов - Пульмонология, 2020 - journal.pulmonology.ru
Аннотация В декабре 2019 г. началась эпидемия тяжелой инфекции, вызванной новым
представителем семейства коронавирусов, позже объявленная Всемирной …

Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case–control and population case–control design

R Murtas, A Andreano, F Gervasi, D Guido… - Autoimmunity …, 2020 - Springer
Background COVID-19 epidemic has paralleled with the so called infodemic, where
countless pieces of information have been disseminated on putative risk factors for COVID …

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes

E Kastritis, GD Kitas, D Vassilopoulos… - Rheumatology …, 2020 - Springer
As of June 10th 2020 about 7.2 million individuals have tested positive for, and more than
410,000 have died due to COVID-19. In this review we outline the pathophysiology that …

Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic

LS Tam, Y Tanaka, R Handa, Z Li… - International Journal …, 2021 - Wiley Online Library
Aim To update previous guidance of the Asia Pacific League of Associations for
Rheumatology (APLAR) on the management of patients with rheumatic and musculoskeletal …

The psychological impact of the COVID-19 pandemic on Dutch people with and without an inflammatory rheumatic disease

TY Koppert, JWG Jacobs, R Geenen - Rheumatology, 2021 - academic.oup.com
Objectives To determine the psychological impact of the COVID-19 pandemic on people
with and without an inflammatory rheumatic disease and establish whether psychological …